EssilorLuxottica S.A.
ESLOYOTCHealthcare● Active
$99.69
+$0.38(+0.38%)
Market Cap$91.8B
P/E Ratio—
52W High$186.81
52W Low$96.56
EssilorLuxottica S.A. (ESLOY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ESLOY · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 11, 2026EPS Actual
$1.73
Est. $1.57 · +10.2%
Revenue
$17.19B
Est. $16.31B · +5.4%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 11, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
ESLOY reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$3.83
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | $2.06 | — | — | — | $17.52B | — |
| ▲ Q1 FY2026 | Feb 11, 2026 | $1.57 | $1.73 | +10.2% | $17.19B | $16.31B | +5.4% |
| ▼ Q2 FY2025 | Jun 30, 2025 | $2.29 | $1.77 | -22.7% | $16.51B | $16.17B | +2.1% |
| ▼ Q4 FY2024 | Dec 31, 2024 | $1.45 | $1.12 | -22.8% | $13.69B | $13.54B | +1.1% |
| ▼ Q2 FY2024 | Jun 29, 2024 | $1.99 | $1.60 | -19.6% | $14.29B | $14.50B | -1.5% |
| ▼ Q4 FY2023 | Dec 31, 2023 | $1.52 | $1.13 | -25.7% | $13.80B | $13.73B | +0.5% |
| ▼ Q2 FY2023 | Jun 30, 2023 | $1.93 | $1.65 | -14.5% | $14.02B | $14.30B | -2.0% |
| ▼ Q4 FY2022 | Dec 31, 2022 | $1.33 | $1.18 | -11.3% | $13.46B | $13.45B | +0.1% |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
$2.06
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 11, 2026Beat
EPS Actual
$1.73
EPS Est.
$1.57
EPS Surpr.
+10.2%
Revenue
$17.19B
Q2 FY2025
Jun 30, 2025Miss
EPS Actual
$1.77
EPS Est.
$2.29
EPS Surpr.
-22.7%
Revenue
$16.51B
Q4 FY2024
Dec 31, 2024Miss
EPS Actual
$1.12
EPS Est.
$1.45
EPS Surpr.
-22.8%
Revenue
$13.69B
Q2 FY2024
Jun 29, 2024Miss
EPS Actual
$1.60
EPS Est.
$1.99
EPS Surpr.
-19.6%
Revenue
$14.29B
Q4 FY2023
Dec 31, 2023Miss
EPS Actual
$1.13
EPS Est.
$1.52
EPS Surpr.
-25.7%
Revenue
$13.80B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
$1.65
EPS Est.
$1.93
EPS Surpr.
-14.5%
Revenue
$14.02B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
$1.18
EPS Est.
$1.33
EPS Surpr.
-11.3%
Revenue
$13.46B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $1.45 | $1.45 | $1.45 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $6.6B | $6.6B | $6.6B | 1 |
| Q2 FY2026 | $8.0B | $8.0B | $8.0B | 1 |
| Q1 FY2026 | $6.2B | $6.2B | $6.3B | 5 |
| Q4 FY2025 | $6.9B | $7.0B | $7.1B | 2 |
| Q3 FY2025 | $5.7B | $5.7B | $5.8B | 4 |
| Q2 FY2025 | $6.1B | $6.1B | $6.2B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 11, 2026 | +10.2% | $149.14 | $167.00 | +11.98% |
| ▼ Q2 FY2025 | Jun 30, 2025 | -22.7% | $136.85 | $137.24 | +0.28% |
| ▼ Q4 FY2024 | Dec 31, 2024 | -22.8% | $121.31 | $120.67 | -0.53% |
| ▼ Q2 FY2024 | Jun 29, 2024 | -19.6% | $108.38 | $108.44 | +0.06% |
| ▼ Q4 FY2023 | Dec 31, 2023 | -25.7% | $100.49 | $99.18 | -1.30% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -14.5% | $91.74 | $94.34 | +2.83% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -11.3% | $90.58 | $90.04 | -0.60% |
| ▼ Q2 FY2022 | Jun 30, 2022 | -13.2% | $74.93 | $74.83 | -0.13% |
Q1 FY2026+11.98%
Report Date
Feb 11, 2026
EPS Beat/Miss
+10.2%
Price Before
$149.14
Price After
$167.00
Q2 FY2025+0.28%
Report Date
Jun 30, 2025
EPS Beat/Miss
-22.7%
Price Before
$136.85
Price After
$137.24
Q4 FY2024-0.53%
Report Date
Dec 31, 2024
EPS Beat/Miss
-22.8%
Price Before
$121.31
Price After
$120.67
Q2 FY2024+0.06%
Report Date
Jun 29, 2024
EPS Beat/Miss
-19.6%
Price Before
$108.38
Price After
$108.44
Q4 FY2023-1.30%
Report Date
Dec 31, 2023
EPS Beat/Miss
-25.7%
Price Before
$100.49
Price After
$99.18
Q2 FY2023+2.83%
Report Date
Jun 30, 2023
EPS Beat/Miss
-14.5%
Price Before
$91.74
Price After
$94.34
Q4 FY2022-0.60%
Report Date
Dec 31, 2022
EPS Beat/Miss
-11.3%
Price Before
$90.58
Price After
$90.04
Q2 FY2022-0.13%
Report Date
Jun 30, 2022
EPS Beat/Miss
-13.2%
Price Before
$74.93
Price After
$74.83
Avg Beat Reaction+11.98%
Avg Miss Reaction+0.09%
Beat Rate1 / 8 quarters
Largest Move+11.98% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ESLOY ends December
EssilorLuxottica S.A. (ESLOY) most recently reported earnings on February 11, 2026 for Q1 FY2026, posting EPS of $1.73 — beating the analyst consensus of $1.57 by +10.2%. The next ESLOY earnings date is expected around September 1, 2026.
Each quarter, investors track ESLOY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ESLOY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ESLOY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ESLOY earnings · 5 questionsEssilorLuxottica S.A.'s next earnings report is expected around September 1, 2026. ESLOY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ESLOY historically reports after market close (AMC).
ESLOY earnings datewhen is ESLOY earningsESLOY next earnings datewhen does ESLOY report earningsESLOY earnings calendar
▸ Source: FMP · EssilorLuxottica S.A. SEC filings · US GAAP · EssilorLuxottica S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026